Low Expression of lncRNA-GAS5 Is Implicated in Human Primary Varicose Great Saphenous Veins
暂无分享,去创建一个
Xiang Li | Jing Wang | Yingyu Cui | Erlinda The | Yahan Wu | Li-jie Wang | T. Yuan | Jing Feng | Yuan Liu | Shiyi Wang | Li Li | Xiu-E Ma | Jin Ge | Xiao-Yan Jiang | Erlinda The
[1] Xiang Li,et al. Aberrantly Expressed lncRNAs in Primary Varicose Great Saphenous Veins , 2014, PloS one.
[2] Tsung-Han Lee,et al. Increased expression of hypoxia-inducible factor-1alpha and Bcl-2 in varicocele and varicose veins. , 2012, Annals of vascular surgery.
[3] Jing Huang,et al. Dissecting the role of disulfide bonds on the amyloid formation of insulin. , 2012, Biochemical and biophysical research communications.
[4] J. Hesketh,et al. Selenium Promotes T-Cell Response to TCR-Stimulation and ConA, but Not PHA in Primary Porcine Splenocytes , 2012, PloS one.
[5] T. Lee,et al. Increased expression of hypoxia-inducible factor-1α and metallothionein in varicocele and varicose veins , 2012, Phlebology.
[6] Yan Zeng,et al. Knockdown of ZNF268, which Is Transcriptionally Downregulated by GATA-1, Promotes Proliferation of K562 Cells , 2012, PloS one.
[7] Shuhan Sun,et al. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans , 2011, Hepatology.
[8] M. Mourtada-Maarabouni,et al. A critical role for non-coding RNA GAS5 in growth arrest and rapamycin inhibition in human T-lymphocytes. , 2011, Biochemical Society transactions.
[9] John S. Mattick,et al. lncRNAdb: a reference database for long noncoding RNAs , 2010, Nucleic Acids Res..
[10] T. Efferth,et al. Cajanol, a novel anticancer agent from Pigeonpea [Cajanus cajan (L.) Millsp.] roots, induces apoptosis in human breast cancer cells through a ROS-mediated mitochondrial pathway. , 2010, Chemico-biological interactions.
[11] Ying Zhang,et al. 1, 5-Dicaffeoylquinic acid-mediated glutathione synthesis through activation of Nrf2 protects against OGD/reperfusion-induced oxidative stress in astrocytes , 2010, Brain Research.
[12] M. Mourtada-Maarabouni,et al. Inhibition of Human T-Cell Proliferation by Mammalian Target of Rapamycin (mTOR) Antagonists Requires Noncoding RNA Growth-Arrest-Specific Transcript 5 (GAS5) , 2010, Molecular Pharmacology.
[13] R. Webster,et al. Association of RIG-I with innate immunity of ducks to influenza , 2010, Proceedings of the National Academy of Sciences.
[14] G. Chrousos,et al. Noncoding RNA Gas5 Is a Growth Arrest– and Starvation-Associated Repressor of the Glucocorticoid Receptor , 2010, Science Signaling.
[15] A. Davies,et al. Pathogenesis of primary varicose veins , 2009, The British journal of surgery.
[16] R. Khalil,et al. Inflammatory cytokines in vascular dysfunction and vascular disease. , 2009, Biochemical pharmacology.
[17] D. Spector,et al. Long noncoding RNAs: functional surprises from the RNA world. , 2009, Genes & development.
[18] M. Barbacid,et al. Cell cycle, CDKs and cancer: a changing paradigm , 2009, Nature Reviews Cancer.
[19] M. Mourtada-Maarabouni,et al. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer , 2009, Oncogene.
[20] M. Reijnen,et al. Treatment of recurrent varicose veins of the great saphenous vein by conventional surgery and endovenous laser ablation. , 2009, Journal of vascular surgery.
[21] M. Mourtada-Maarabouni,et al. Growth arrest in human T-cells is controlled by the non-coding RNA growth-arrest-specific transcript 5 (GAS5) , 2008, Journal of Cell Science.
[22] J. Raffetto,et al. Mechanisms of varicose vein formation: valve dysfunction and wall dilation , 2008, Phlebology.
[23] J. Bai,et al. Involvement of Annexin A2 in p53 induced apoptosis in lung cancer , 2008, Molecular and Cellular Biochemistry.
[24] Seshadri Raju,et al. Primary chronic venous disorders. , 2007, Journal of vascular surgery.
[25] G. Schmid-Schönbein,et al. Chronic venous disease. , 2006, Minerva cardioangiologica.
[26] G. Moneta,et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. , 2004, Journal of vascular surgery.
[27] D. Waisman,et al. Annexin A2 Is a Novel RNA-binding Protein , 2004, Journal of Biological Chemistry.
[28] A. Rizzino,et al. Specific down-regulation of annexin II expression in human cells interferes with cell proliferation , 1999, Molecular and Cellular Biochemistry.
[29] A. Marks. Rapamycin: signaling in vascular smooth muscle. , 2003, Transplantation Proceedings.
[30] P. Allan,et al. Lifestyle risk factors for lower limb venous reflux in the general population: Edinburgh Vein Study. , 2001, International journal of epidemiology.
[31] T. Jacob,et al. Expression of molecular mediators of apoptosis and their role in the pathogenesis of lower-extremity varicose veins. , 2001, Journal of vascular surgery.
[32] B. Hambly,et al. Growth arrest‐specific gene 6 expression in proliferating rabbit vascular smooth muscle cells in vitro and in vivo , 2000, Electrophoresis.
[33] G. Schmid-Schönbein,et al. Expression of Adhesion Molecules and Cytokines on Saphenous Veins in Chronic Venous Insufficiency , 2000, Annals of vascular surgery.
[34] E. Nabel,et al. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation. , 2000, Circulation.
[35] J. Vishwanatha,et al. Annexin II expression is regulated during mammalian cell cycle. , 1993, Cancer research.
[36] J. Vishwanatha,et al. Enhanced levels of annexins in pancreatic carcinoma cells of Syrian hamsters and their intrapancreatic allografts. , 1992, Cancer research.